Age: 33.0
Sex: F
Vaccine: COVID19, HEP, MMR, VARCEL
Symptoms: Expired product administered, Pain
Clinical narrative: Patient complained of being achy for 3 days after vaccines; patient was given a Moderna vaccine that had expired on 5/1/24; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (Patient complained of being achy for 3 days after vaccines) and EXPIRED PRODUCT ADMINISTERED (patient was given a Moderna vaccine that had expired on 5/1/24) in a 33-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 203F23A) for COVID-19 prophylaxis.    Co-suspect products included non-company products HEPATITIS B VACCINE for an unknown indication, MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR VACCIN) for an unknown indication and VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) for an unknown indication.    Patient had no chronic problems.  Concomitant products included PRENATAL MULTIVITAMIN + DHA for Supplementation therapy.   On 04-Jun-2024, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use) .5 milliliter, dose of HEPATITIS B VACCINE (Intramuscular use) 1 dosage form and dose of MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR VACCIN) (Subcutaneous use) 1 dosage form. On an unknown date, the patient received dose of VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) (unknown route) 1 dosage form. On 04-Jun-2024, the patient experienced PAIN (Patient complained of being achy for 3 days after vaccines) and EXPIRED PRODUCT ADMINISTERED (patient was given a Moderna vaccine that had expired on 5/1/24). On 04-Jun-2024, EXPIRED PRODUCT ADMINISTERED (patient was given a Moderna vaccine that had expired on 5/1/24) had resolved. On 06-Jun-2024, PAIN (Patient complained of being achy for 3 days after vaccines) had resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use), the reporter did not provide any causality assessments.   Patient had no allergies, no chronic issues/problems.  Vaccine did not undergo any temperature excursions and it was thawed on the same day it was administered.   Reporter did not have information on previous covid vaccine the patient received.  Patient did not receive any vaccine 4 weeks prior to this vaccine.  Moderna vaccine site of administration was reported as Deltoid.  Hepatitis B vaccine and MMR VACCIN site of administration was reported as Deltoid.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2024: Live follow up received contains no significant information. Reference id added. On 04-Jun-2024: Live significant follow up received. Updated reporter details. Added Patient details. Updated Suspect product coding and narrative. On 07-Jun-2024: Live follow up received contains no new information. On 12-Jun-2024: Follow-up information received included significant information, updated reporter occupation from Other Health Care Professional to Nurse, added patient details, updated patient's Race information from UNKNOWN to OTHER, added suspect product route of administration, added non-company co-suspect, added concomitant medication, added event of Pain, removed event of No adverse event and updated narrative.